These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
412 related items for PubMed ID: 12899749
21. [Mutation and amplification of RIT1 gene in hepatocellular carcinoma]. Li JT, Liu W, Kuang ZH, Zhang RH, Chen HK, Feng QS. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):43-6. PubMed ID: 14767908 [Abstract] [Full Text] [Related]
22. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. Huang LR, Hsu HC. Cancer Res; 1995 Oct 15; 55(20):4717-21. PubMed ID: 7553654 [Abstract] [Full Text] [Related]
23. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma. Takuma Y, Nouso K, Kobayashi Y, Nakamura S, Tanaka H, Matsumoto E, Fujikawa T, Suzuki M, Hanafusa T, Shiratori Y. J Gastroenterol Hepatol; 2004 Nov 15; 19(11):1300-4. PubMed ID: 15482538 [Abstract] [Full Text] [Related]
24. [Expression of MAGE-B genes in hepatocellular carcinoma]. Mou DC, Leng XS, Peng JR, Zhao L, Wang WX, Wang Y, Li T, Zhang LG, Huang L, Zhu JY. Zhonghua Zhong Liu Za Zhi; 2004 Jan 15; 26(1):40-2. PubMed ID: 15059354 [Abstract] [Full Text] [Related]
25. Expression of cancer-testis antigen (CTA) in tumor tissues and peripheral blood of Chinese patients with hepatocellular carcinoma. Wu LQ, Lu Y, Wang XF, Lv ZH, Zhang B, Yang JY. Life Sci; 2006 Jul 17; 79(8):744-8. PubMed ID: 16546222 [Abstract] [Full Text] [Related]
26. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma]. Dong LH, Li H, Wang F, Li FQ, Zhou HY, Yang HJ. Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar 17; 27(3):318-21. PubMed ID: 17425983 [Abstract] [Full Text] [Related]
27. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis. Sasaki A, Ishikawa K, Haraguchi N, Inoue H, Ishio T, Shibata K, Ohta M, Kitano S, Mori M. Ann Surg Oncol; 2007 Mar 17; 14(3):1191-9. PubMed ID: 17195907 [Abstract] [Full Text] [Related]
28. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma. Ikeguchi M, Iwamoto A, Taniguchi K, Katano K, Hirooka Y. J Exp Clin Cancer Res; 2005 Sep 17; 24(3):415-21. PubMed ID: 16270528 [Abstract] [Full Text] [Related]
29. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma]. Chen G, Luo DZ, Wang Y, Liao ZL, Zhang MY. Zhonghua Bing Li Xue Za Zhi; 2007 Feb 17; 36(2):113-7. PubMed ID: 17493386 [Abstract] [Full Text] [Related]
30. The relationship between point mutation and abnormal expression of c-fms oncogene in hepatocellular carcinoma. Yang DH, Huang W, Cui J, Shu JC, Tang SH, Zhang WJ, Liang JH. Hepatobiliary Pancreat Dis Int; 2004 Feb 17; 3(1):86-9. PubMed ID: 14969845 [Abstract] [Full Text] [Related]
31. [The genetic polymorphism of melanoma-associated antigen 1 in Chinese normal donors and hepatoma patients]. Wang LP, Chen HS, Mei MH, Qin LL, Cong X, Fei R, Xu J, Wei L. Zhonghua Gan Zang Bing Za Zhi; 2004 Mar 17; 12(3):151-5. PubMed ID: 15059299 [Abstract] [Full Text] [Related]
32. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma]. Zhang G, Zhang SJ, Zhao YF, Wu Y, Li Z, Wang JX. Zhonghua Wai Ke Za Zhi; 2007 Apr 01; 45(7):499-502. PubMed ID: 17686315 [Abstract] [Full Text] [Related]
33. Gene and protein expression of RCAS1 in hepatocellular carcinoma. Ikeguchi M, Hirooka Y, Kaibara N. Anticancer Res; 2003 Apr 01; 23(6D):4967-71. PubMed ID: 14981953 [Abstract] [Full Text] [Related]
34. RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs. Furumoto K, Arii S, Mori A, Furuyama H, Gorrin Rivas MJ, Nakao T, Isobe N, Murata T, Takahashi C, Noda M, Imamura M. Hepatology; 2001 Jan 01; 33(1):189-95. PubMed ID: 11124835 [Abstract] [Full Text] [Related]
35. [Expression of MAGE-1 gene in hepatocellular carcinoma]. Cai S, Chen H, Wang Y. Zhonghua Yi Xue Za Zhi; 1999 Sep 01; 79(9):668-72. PubMed ID: 11715455 [Abstract] [Full Text] [Related]
36. [Expression of telomerase reverse transcriptase and its relationship with tumor suppressor gene p53 in HCC]. Dai D, Zhai W, Zhu T, Zhu H, Ling Y. Zhonghua Gan Zang Bing Za Zhi; 2001 Jul 01; 9 Suppl():79-81. PubMed ID: 11509149 [Abstract] [Full Text] [Related]
37. [Expression and significance of MXR7 mRNA in human hepatocellular carcinoma]. Zhou X, Wang H, Yang G, Chen Z, Li B, Wu M. Zhonghua Wai Ke Za Zhi; 1999 Mar 01; 37(3):171-3, 10. PubMed ID: 11829813 [Abstract] [Full Text] [Related]
38. [Focal adhesion kinase mRNA overexpression in hepatocellular carcinoma HCC) and correlation thereof with prognosis of HCC]. Yuan Z, Fan J, Wu ZQ, Zhou J, Qiu SJ. Zhonghua Yi Xue Za Zhi; 2007 May 15; 87(18):1256-9. PubMed ID: 17686260 [Abstract] [Full Text] [Related]
39. [Effect of p16 gene on carcinogenesis of hepatitis B virus related hepatocellular carcinoma]. Wang ZW, Peng ZH, Li K, Qiu GQ, Zhang Y, Gu W. Zhonghua Zhong Liu Za Zhi; 2003 Jul 15; 25(4):356-8. PubMed ID: 12921565 [Abstract] [Full Text] [Related]
40. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma. Morinaga S, Nakamura Y, Ishiwa N, Yoshikawa T, Noguchi Y, Yamamoto Y, Rino Y, Imada T, Takanashi Y, Akaike M, Sugimasa Y, Takemiya S. Oncol Rep; 2004 Dec 15; 12(6):1189-94. PubMed ID: 15547736 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]